2021 Investor Day

Speaker Biographies Hemanth Reddy Chief Strategy Officer Hemanth Reddy was appointed ResMed's chief strategy officer in September 2013, responsible for the company's global corporate strategy and corporate development functions. Prior to joining ResMed, Hemanth was a strategy consultant for 14 years, advising on a range of issues including corporate strategy, business unit strategy, portfolio strategy, and inorganic growth strategy across consumer products, high tech, biotech and other industries. He was most recently a principal with Monitor Deloitte, Deloitte Consulting's Strategy practice, co-leading its San Francisco office. Prior to Deloitte, he was a partner with Monitor Group where he co-led corporate finance activities in North America and shared leadership responsibility for Monitor's Mergers & Acquisitions advisory practice. Before Monitor Group, he was an investment banker with Donaldson, Lufkin & Jenrette (DLJ) in New York, where he advised clients in structuring and executing debt and equity offerings, as well as private equity transactions. Hemanth holds a Master of Business Administration in Finance, Strategy and Marketing from Northwestern University's Kellogg School of Management and a bachelor's in computer science from Cornell University's College of Engineering. O2021 ResMed | 2021 Investor Day – Sept 8, 2021 - 94

View entire presentation